Vascular Solutions, Inc. (VASC) Tops Q2 EPS by 2c; Raises FY12 Outlook
Tweet
Share
E-mailGet Alerts VASC Hot Sheet
Join SI Premium – FREE
Vascular Solutions, Inc. (NASDAQ: VASC) reported Q2 EPS of $0.15, $0.02 better than the analyst estimate of $0.13. Revenue for the quarter came in at $24.7 million versus the consensus estimate of $24.15 million.
Vascular Solutions, Inc. sees FY2012 EPS of $0.57-$0.59, versus prior guidance of $0.53-$0.57 and the consensus of $0.56. Vascular Solutions, Inc. sees FY2012 revenue of $97.5-$99.5 million, versus prior guidance of $96-$98 million and the consensus of $97.52 million.
For earnings history and earnings-related data on Vascular Solutions, Inc. (VASC) click here.
Vascular Solutions, Inc. sees FY2012 EPS of $0.57-$0.59, versus prior guidance of $0.53-$0.57 and the consensus of $0.56. Vascular Solutions, Inc. sees FY2012 revenue of $97.5-$99.5 million, versus prior guidance of $96-$98 million and the consensus of $97.52 million.
For earnings history and earnings-related data on Vascular Solutions, Inc. (VASC) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Biogen (BIIB) tops earnings expectations but revenue falls short
- AT&T (T) beats earnings estimates in Q1 but revenue falls short, shares climb
- Masco Corp. (MAS) Tops Q1 EPS by 5c; offers guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
